We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+6%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$1B
AUM Growth
+$95.8M
Cap. Flow
+$49M
Cap. Flow %
4.89%
Top 10 Hldgs %
46.74%
Holding
1,116
New
33
Increased
141
Reduced
150
Closed
45

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$12.9M
2
MSFT icon
Microsoft
MSFT
+$8.08M
3
DIS icon
Walt Disney
DIS
+$5.58M
4
V icon
Visa
V
+$4.43M
5
PAYC icon
Paycom
PAYC
+$1.87M

Sector Composition

Rank Sector Weight
1 Financials 24.26%
2 Technology 18.42%
3 Consumer Discretionary 16.46%
4 Communication Services 11.34%
5 Healthcare 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDD icon
1026
3D Systems Corp
DDD
$545M
$546 ﹤0.01%
60
SRRA
1027
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$546 ﹤0.01%
24
TRQ
1028
DELISTED
Turquoise Hill Resources Ltd
TRQ
$496 ﹤0.01%
40
VIAV icon
1029
Viavi Solutions
VIAV
$9.02B
$492 ﹤0.01%
+37
New +$479
GROW icon
1030
US Global Investors
GROW
$41.3M
$489 ﹤0.01%
270
VXRT
1031
DELISTED
Vaxart
VXRT
$470 ﹤0.01%
701
LTHM
1032
DELISTED
Livent Corporation
LTHM
$464 ﹤0.01%
67
CLNE icon
1033
Clean Energy Fuels
CLNE
$359M
$427 ﹤0.01%
160
MERC icon
1034
Mercer International
MERC
$25.9M
$402 ﹤0.01%
26
EMWP
1035
DELISTED
Eros Media World PLC
EMWP
$401 ﹤0.01%
15
-17
-53% -$2.29K
GLBS icon
1036
Globus Maritime Ltd
GLBS
$76.4M
$393 ﹤0.01%
2
GNMK
1037
DELISTED
GenMark Diagnostics, Inc
GNMK
$357 ﹤0.01%
55
-1,735
-97% -$12.2K
MNK
1038
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$340 ﹤0.01%
37
MNKD icon
1039
MannKind Corp
MNKD
$1.27B
$322 ﹤0.01%
280
UVXY icon
1040
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$276M
0
CGRN
1041
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$315 ﹤0.01%
40
TWI icon
1042
Titan International
TWI
$453M
$298 ﹤0.01%
61
GALT icon
1043
Galectin Therapeutics
GALT
$405M
$166 ﹤0.01%
40
ELOX
1044
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
0
FRO icon
1045
Frontline
FRO
$9.84B
$112 ﹤0.01%
14
CRC
1046
DELISTED
California Resources Corporation
CRC
$98 ﹤0.01%
5
KZIA
1047
Kazia Therapeutics
KZIA
$155M
$83 ﹤0.01%
1
QCLS
1048
Q/C Technologies Inc
QCLS
$19.2M
0
BLRX
1049
BioLineRX
BLRX
$11.4M
0
TPST icon
1050
Tempest Therapeutics
TPST
$17.5M
0

Similar funds

RBC Europe's Q2 2019 Portfolio in Review

As of Q2 2019, RBC Europe held 1,116 positions worth $1B, up 11% from $905M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

RBC Europe deployed $49M of net new capital in Q2 2019, opening 33 new positions and adding to 141 existing holdings. Its largest new stake was Paycom: 9,110 shares worth $2.07M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $1.48M trimmed.

  • RBC Europe's largest Q2 2019 buy was Paycom: 9,110 shares worth $2.07M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2019, an estimated $12.9M increase.
  • RBC Europe's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $1.48M.
  • RBC Europe fully exited Usg in Q2 2019, selling an estimated $1.04M.
  • RBC Europe's ten largest holdings make up 47% of its $1B portfolio in Q2 2019.
  • RBC Europe opened 33 new positions and closed 45 in Q2 2019.
  • RBC Europe's portfolio value rose 11% quarter-over-quarter to $1B.

Based on RBC Europe's 13F filing for Q2 2019, filed 9 Nov 2023.